Crossmark

Evaluation of the risk factors predicting thrombotic complications associated with intravenous immunoglobulin therapy in neuroimmunological diseases

Published Online: 2021-04-21

Published Print: 2021-12

Authors

Noda, Kotaro

Yagi, Yohsuke

Yokota, Takanori https://orcid.org/0000-0002-6490-3263
License Information

Text and Data Mining valid from 2021-04-21

Version of Record valid from 2021-04-21
More Information

Article History

Received: 14 October 2020

Accepted: 16 March 2021

First Online: 21 April 2021

Declarations

:

: The authors declare no competing interests.

: The protocols for this study were approved by the local ethics committee of the Tokyo Medical and Dental University (M2018-308).

: Since this study was a retrospective observational study, written informed consent was not obtained from the patients, and requirement for informed consent was waived by the institutional review board. However, we gave patients an opportunity to opt out of the study.

Document is current